First class know-how for Biotech start-ups

Examples like Esbatech or Molecular Partners show that Switzerland is a good country for Biotech start-ups. The scientific know-how in this field is outstanding and in addition there is an excellent industry cluster.
 
But nevertheless it’s not easy to start a company in this industry. The founders have to manage a lot of very different tasks ranging from an efficient development process to safety issues and production or business issues like financing.
 
To make the start easier the Swiss Biotech Association (SBA) launches the SBA Academy in cooperation with CTI and SWITT. The goal of the academy is to inform young entrepreneurs in Biotech about all necessary steps to execute successfully the project development. High-class professionals with special  know-how share their knowledge and  experience.  Speakers include managers from big pharma, entrepreneurs like Christian Zahnd (Molecular Partners) or Bettina Ernst (Preclin Biosystems) and persons from government agencies and Swissmedic.
 
Start-up companies profit from the practical content and the networking opportunities with professionals who are faced daily with issues and challenges in Drug Discovery and Drug Delivery.
 
There will be five one-day modules focusing on the topics of drug discovery, non-clinical development, clinical development, manufacturing, clinical development and strategy. Fee for CTI start-up companies, members of SBA, switt and academia: CHF 150/module, CHF 750 for full package. Fee for all others: CHF 950/module, CHF 3‘800 for full package.
 
More information can be found on the SBA website and in the PDF document below.